The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy
Lars Hanker(Goethe University Frankfurt), Sibylle Loibl(German Breast group), Nicole Burchardi(Center for Clinical Studies), Jacobus Pfisterer(Städtisches Klinikum Solingen), Werner Meier, Éric Pujade-Lauraine(Hôtel-Dieu de Paris), Isabelle Ray‐Coquard(Centre Léon Bérard), Jalid Sehouli(Charité - Universitätsmedizin Berlin), Philipp Harter(Kliniken Essen-Mitte), Andreas du Bois(Kliniken Essen-Mitte)
Cited by 338
Abstract
Related Papers
No related papers found
Powered by citation graph analysis